 MONTREAL and CHARLOTTE, N.C., May 17, 2021 PRNewswire -- Milestone Pharmaceuticals Inc. Nasdaq: MIST, a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the first quarter ended March 31, 2021 and provided a clinical, regulatory, and corporate update. 